{"id":1072,"date":"2025-04-17T16:41:55","date_gmt":"2025-04-17T16:41:55","guid":{"rendered":"http:\/\/thenewamore.com\/?p=1072"},"modified":"2025-04-18T14:26:15","modified_gmt":"2025-04-18T14:26:15","slug":"daily-glp-1-pill-effective-for-diabetes-and-obesity-eli-lilly-says","status":"publish","type":"post","link":"http:\/\/thenewamore.com\/index.php\/2025\/04\/17\/daily-glp-1-pill-effective-for-diabetes-and-obesity-eli-lilly-says\/","title":{"rendered":"Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says"},"content":{"rendered":"
\n\t\t<\/div>\n
A daily pill from drugmaker Eli Lilly has shown similar effectiveness at helping people reduce blood sugar levels and lose weight compared to leading injectable GLP-1 drugs Mounjaro and Ozempic, the company announced.<\/p>\n
The once-daily pill, called orforglipron, helped patients with Type 2 diabetes during late-stage trials and has shown comparable safety results to the injectables, the drugmaker said.<\/p>\n
The trial results are being closely watched, as a needle-free anti-obesity drug could give Lilly a major edge over its well-established rivals. <\/p>\n
GLP-1s are a class of drugs that have become blockbusters for the way they help people lose weight. But they are expensive, must be refrigerated and are delivered through an injection. A daily pill version could make the drugs much more accessible. <\/p>\n